Co-Diagnostics, Inc. Operating Expenses
Co-Diagnostics, Inc. (CODX) reported Operating Expenses of $6.32 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- Co-Diagnostics, Inc. operating expenses for the quarter ending 2026-06-30 was $6.32M, a 22.80% decline year-over-year.
- Co-Diagnostics, Inc. operating expenses for the quarter ending 2026-03-31 was $9.16M, a 6.76% increase year-over-year.
- Co-Diagnostics, Inc. operating expenses for the quarter ending 2025-12-31 was $26.66M, a 125.94% increase year-over-year.
- Co-Diagnostics, Inc. operating expenses for the quarter ending 2025-09-30 was $7.13M, a 32.57% decline year-over-year.
- Co-Diagnostics, Inc. operating expenses for fiscal 2025 was $50.57M, a 17.60% increase from fiscal 2024.
- Co-Diagnostics, Inc. operating expenses for fiscal 2024 was $43.00M, a 5.15% decline from fiscal 2023.
- Co-Diagnostics, Inc. operating expenses for fiscal 2023 was $45.33M, a 18.64% decline from fiscal 2022.
- Co-Diagnostics, Inc. operating expenses for fiscal 2022 was $55.72M, a 38.44% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.32M 10-Q · filed 2026-08-13 | $15.48M 10-Q · filed 2026-08-13 | $42.15M derived: sum of 3 quarters · filed 2026-08-13 | $49.28M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $9.16M 10-Q · filed 2026-05-14 | $35.82M derived: sum of 2 quarters · filed 2026-05-14 | $42.96M derived: sum of 3 quarters · filed 2026-05-14 | $51.15M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $26.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $33.80M derived: sum of 2 quarters · filed 2026-03-31 | $41.98M derived: sum of 3 quarters · filed 2026-08-13 | $50.57M 10-K · filed 2026-03-31 |
| 2025-09-30 | $7.13M 10-Q · filed 2025-11-13 | $15.32M derived: sum of 2 quarters · filed 2026-08-13 | $23.90M 10-Q · filed 2025-11-13 | $35.70M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $8.19M 10-Q · filed 2026-08-13 | $16.77M 10-Q · filed 2026-08-13 | $28.57M derived: sum of 3 quarters · filed 2026-08-13 | $39.15M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $8.58M 10-Q · filed 2026-05-14 | $20.38M derived: sum of 2 quarters · filed 2026-05-14 | $30.96M derived: sum of 3 quarters · filed 2026-05-14 | $41.09M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $11.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $22.38M derived: sum of 2 quarters · filed 2026-03-31 | $32.50M derived: sum of 3 quarters · filed 2026-03-31 | $43.00M 10-K · filed 2026-03-31 |
| 2024-09-30 | $10.58M 10-Q · filed 2025-11-13 | $20.70M derived: sum of 2 quarters · filed 2025-11-13 | $31.20M 10-Q · filed 2025-11-13 | $43.61M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $10.12M 10-Q · filed 2025-08-14 | $20.62M 10-Q · filed 2025-08-14 | $33.03M derived: sum of 3 quarters · filed 2025-08-14 | $44.17M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $10.49M 10-Q · filed 2025-05-08 | $22.91M derived: sum of 2 quarters · filed 2025-05-08 | $34.04M derived: sum of 3 quarters · filed 2025-05-08 | $45.78M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $12.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $23.55M derived: sum of 2 quarters · filed 2025-03-27 | $35.28M derived: sum of 3 quarters · filed 2025-03-27 | $45.33M 10-K · filed 2025-03-27 |
| 2023-09-30 | $11.14M 10-Q · filed 2024-11-07 | $22.87M derived: sum of 2 quarters · filed 2024-11-07 | $32.92M 10-Q · filed 2024-11-07 | $59.93M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $11.73M 10-Q · filed 2024-08-08 | $21.78M 10-Q · filed 2024-08-08 | $48.79M derived: sum of 3 quarters · filed 2024-08-08 | $59.65M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $10.05M 10-Q · filed 2024-05-09 | $37.06M derived: sum of 2 quarters · filed 2024-05-09 | $47.92M derived: sum of 3 quarters · filed 2024-05-09 | $56.17M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $27.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $37.87M derived: sum of 2 quarters · filed 2024-03-14 | $46.12M derived: sum of 3 quarters · filed 2024-03-14 | $55.72M 10-K · filed 2024-03-14 |
| 2022-09-30 | $10.86M 10-Q · filed 2023-11-09 | $19.12M derived: sum of 2 quarters · filed 2023-11-09 | $28.71M 10-Q · filed 2023-11-09 | $36.32M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $8.25M 10-Q · filed 2023-08-10 | $17.85M 10-Q · filed 2023-08-10 | $25.45M derived: sum of 3 quarters · filed 2023-08-10 | $38.61M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $9.59M 10-Q · filed 2023-05-11 | $17.20M derived: sum of 2 quarters · filed 2023-05-11 | $30.36M derived: sum of 3 quarters · filed 2023-05-11 | $43.42M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $20.77M derived: sum of 2 quarters · filed 2023-03-16 | $33.83M derived: sum of 3 quarters · filed 2023-03-16 | $40.25M 10-K · filed 2023-03-16 |
| 2021-09-30 | $13.16M 10-Q · filed 2022-11-10 | $26.22M derived: sum of 2 quarters · filed 2022-11-10 | $32.64M 10-Q · filed 2022-11-10 | $39.44M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $13.06M 10-Q · filed 2022-08-11 | $19.48M 10-Q · filed 2022-08-11 | $26.28M derived: sum of 3 quarters · filed 2022-08-11 | $30.24M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $6.42M 10-Q · filed 2022-05-12 | $13.22M derived: sum of 2 quarters · filed 2022-05-12 | $17.18M derived: sum of 3 quarters · filed 2022-05-12 | $20.54M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $10.76M derived: sum of 2 quarters · filed 2022-03-24 | $14.12M derived: sum of 3 quarters · filed 2022-03-24 | $16.27M 10-K · filed 2022-03-24 |
| 2020-09-30 | $3.96M 10-Q · filed 2021-11-12 | $7.32M derived: sum of 2 quarters · filed 2021-11-12 | $9.46M 10-Q · filed 2021-11-12 | $11.14M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $3.36M 10-Q · filed 2021-08-12 | $5.51M 10-Q · filed 2021-08-12 | $7.18M derived: sum of 3 quarters · filed 2021-08-12 | $8.86M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $2.15M 10-Q · filed 2021-05-13 | $3.83M derived: sum of 2 quarters · filed 2021-05-13 | $5.50M derived: sum of 3 quarters · filed 2021-05-13 | $6.89M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $3.35M derived: sum of 2 quarters · filed 2021-03-25 | $4.74M derived: sum of 3 quarters · filed 2021-03-25 | $6.00M 10-K · filed 2021-03-25 |
| 2019-09-30 | $1.67M 10-Q · filed 2020-11-16 | $3.06M derived: sum of 2 quarters · filed 2020-11-16 | $4.32M 10-Q · filed 2020-11-16 | $6.14M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $1.39M 10-Q/A · filed 2020-11-03 | $2.65M 10-Q/A · filed 2020-11-03 | $4.47M derived: sum of 3 quarters · filed 2020-11-03 | $6.14M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-03-31 | $1.26M 10-Q · filed 2020-05-14 | $3.08M derived: sum of 2 quarters · filed 2020-05-14 | $4.76M derived: sum of 3 quarters · filed 2020-05-14 | $6.12M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $3.50M derived: sum of 2 quarters · filed 2020-03-30 | $4.86M derived: sum of 3 quarters · filed 2020-03-30 | $6.15M 10-K · filed 2020-03-30 |
| 2018-09-30 | $1.67M 10-Q · filed 2019-11-12 | $3.04M derived: sum of 2 quarters · filed 2019-11-12 | $4.32M 10-Q · filed 2019-11-12 | $5.82M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $1.36M 10-Q · filed 2019-08-14 | $2.65M 10-Q · filed 2019-08-14 | $4.15M derived: sum of 3 quarters · filed 2019-08-14 | $5.95M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $1.29M 10-Q · filed 2019-05-14 | $2.78M derived: sum of 2 quarters · filed 2019-05-14 | $4.59M derived: sum of 3 quarters · filed 2019-05-14 | $5.29M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $3.30M derived: sum of 2 quarters · filed 2019-04-01 | $4.01M derived: sum of 3 quarters · filed 2019-04-01 | $4.57M 10-K · filed 2019-04-01 |
| 2017-09-30 | $1.81M 10-Q · filed 2018-11-14 | $2.51M derived: sum of 2 quarters · filed 2018-11-14 | $3.08M 10-Q · filed 2018-11-14 | $3.52M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $703.12K 10-Q · filed 2018-08-10 | $1.27M 10-Q · filed 2018-08-10 | $1.71M derived: sum of 3 quarters · filed 2018-08-10 | $2.10M derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | $564.37K 10-Q · filed 2018-05-14 | $1.01M derived: sum of 2 quarters · filed 2018-05-14 | $1.40M derived: sum of 3 quarters · filed 2018-05-14 | $1.79M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $444.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $836.93K derived: sum of 2 quarters · filed 2018-03-28 | $1.23M derived: sum of 3 quarters · filed 2018-03-28 | $1.69M 10-K · filed 2018-03-28 |
| 2016-09-30 | $392.35K 10-Q · filed 2017-11-14 | $782.64K derived: sum of 2 quarters · filed 2017-11-14 | $1.24M 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $390.29K 10-Q · filed 2017-08-25 | $851.04K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |